Efficacy of Adalimumab in Non-Infectious Uveitis Across Different Etiologies: A Post Hoc Analysis of the VISUAL I and VISUAL II Trials
Pauline T. Merrill, Albert T. Vitale, Manfred Zierhut, Hiroshi Gotô, Martina Kron, Alexandra Song, Sophia Pathai, Éric Fortin
Abstract
: Treatment failure risk was lower in patients with idiopathic noninfectious uveitis receiving adalimumab versus those receiving placebo.
Topics & Concepts
MedicineAdalimumabPlaceboUveitisPost-hoc analysisInternal medicineHazard ratioEtiologyPost hocSubgroup analysisProportional hazards modelOphthalmologyConfidence intervalDiseasePathologyAlternative medicineOcular Diseases and Behçet’s SyndromeRetinal and Optic ConditionsVasculitis and related conditions